5 Conjugate Reactions Improving Oligonucleotide Delivery

Oligonucleotides (oligos) are short strands of DNA or RNA that look set to revolutionize the treatment of a range of conditions from cardiovascular diseases to cancers and central nervous system disorders (CNS).Oligos are able to modulate gene expression in a number of ways including through gene activation, expression inhibition, splicing modulation and programmed gene editing. This means they have the potential to provide treatments that are targeted, so they produce fewer side effects.Growth in therapeutic oligonucleotidesMore than 20 synthetic oligonucleotides have already been approved and growth in this new drug category is expected to increase rapidly as confidence in it grows. A staggering 700 oligonucleotide drugs are currently in the pipeline with several already at the clinical trial stage.There are now several classes of therapeutic oligonucleotides grouped according to their action mechanism. The main types include antisense oligonucleotides (ASOs), small interfering RNAs (siRNAs) and RNA aptamers. Using conjugation chemistry to enhance oligonucleotide deliveryHowever, there are a number of challenges that need to be overcome when delivering oligonucleotide therapies, especially to extrahepatic tissues. Issues such as tissue targeting, cellular uptake, tolerability and stability are a primary barrier to broader therapeutic application.One powerful solution to overcoming these challenges is conjugation to a moiety such as a peptide or carbohydrate. The conjugation method you choose is likely to be influenced by a number of factors, such as the drug’s cellular target. This is because different molecules used in conjugation lend themselves to different cellular targets.Oligonucleotide conjugationBelow, five key conjugation chemistries used for oligonucleotide drug delivery are presented. Thiol-Maleimide ConjugationCovalent linkage via thiol-maleimide coupling is a widely used method in peptide and oligonucleotide chemistry, offering an efficient way to create stable conjugates for drug delivery and therapeutic applications. Maleimides are commonly employed for coupling with the reactive thiol groups of peptides or oligonucleotides via Michael addition reactions. This method is highly selective, has fast reaction kinetics, and requires mild reaction conditions, making it an ideal choice for scalable applications.This conjugation method is frequently used to create peptide-oligonucleotide conjugates (POCs), such as cell-penetrating peptides (CPPs) attached to small interfering RNAs (siRNAs). These conjugates significantly enhance the delivery and efficacy of siRNAs by facilitating their escape from endosomes, improving cellular uptake, and enhancing subcellular distribution. The result is an increased pharmacological effect of the cargo oligonucleotide, making thiol-maleimide conjugation a powerful tool for targeted gene silencing therapies.A notable example of thiol-maleimide conjugation in peptide-oligonucleotide delivery is the coupling of (arginine-glycine-aspartic) (cRGD)-siRNA conjugates which help improve the delivery of siRNAs via endosomal escape. They have been reported to enhance cellular uptake, subcellular distribution, and the pharmacological effects of the cargo oligonucleotide.cRGD is a common type of cell penetrating peptide (CPP) used to target αvβ3 integrin receptors which are often upregulated in tumor cells in several cancer types. Disulfide Bond FormationAnother strategy of oligonucleotide conjugation  is using a disulfide bond, a popular way to form POCs. Disulfide bonds are formed through the oxidation of two cysteine residues, where the sulfur atoms from each cysteine’s thiol group (-SH) undergo oxidative coupling to create a covalent S-S bridge.Covalently conjugating GLP1R to an ASO using a disulfide bridge has been shown to enhance the selective cellular uptake of ASOs in target cells. It’s also been found to improve the conjugate’s potency and induce gene expression silencing leading to a reduction in protein levels. This has paved the way for the treatment of conditions like diabetes caused by faulty gene expression in pancreatic β-cells.Click ChemistryClick chemistry, another common conjugation method, provides a powerful way of reliably conjugating moieties to oligonucleotides.That’s because click reactions can be modular, biocompatible and easily scalable. Click chemistry reactions use easily available reagents, are high yielding and stereospecific and they minimize the formation of by-products. What’s more, they can be carried out in an aqueous environment and they also use simple product separation techniques. They can be used in a wide range of applications such as antibody-oligo conjugates, as well as peptide-oligo conjugates.Conjugation through Oxime, Thiazolidine, or Hydrazone BondsAnother strategy for linking peptides and oligonucleotides is conjugation through oxime, thiazolidine, or hydrazone bonds. These methods offer the advantage of operating under mild conditions, making them ideal for maintaining the stability of both the peptide and oligonucleotide components.The process involves the reaction of carbonyl compounds – such as aldehydes or glyoxylic acid derivatives – with functional groups on the peptide, such as aminooxy, 1,2-aminothiol, or hydrazine groups. The result is the formation of highly stable oxime, thiazolidine, or hydrazone bonds between the two molecules.One of the key benefits of this method is its ability to form covalent bonds under mild conditions, making it highly efficient and suitable for sensitive biological applications. For instance, an oligonucleotide modified with a carbonyl group can be conjugated with a peptide containing an aminooxy group, producing a stable peptide-oligonucleotide conjugate. This type of conjugation is particularly useful for oligonucleotide drug delivery, where maintaining the integrity of the cargo is crucial for therapeutic success.Conjugation through Amide BondsAmide bond formation is another widely used method for creating peptide-oligonucleotide conjugates. This approach involves the simple yet robust reaction of a carboxyl group on one molecule with an amine group on another, resulting in a stable and covalent linkage.Amide bonds are preferred in many applications because of their simplicity and the strength of the bond they form. In the context of therapeutic oligonucleotides, this conjugation strategy ensures a stable, reliable connection between the oligonucleotide and peptide, which is essential for effective cellular delivery.The mild reaction conditions for amide bond formation are another benefit, making it easy to adapt this method to a wide variety of peptide and oligonucleotide structures. As a result, amide bond conjugation has become a cornerstone of oligonucleotide drug delivery systems, offering an effective way to enhance the bioavailability and stability of these promising therapeutics.Bachem and conjugation chemistryThe therapeutic use of oligonucleotides signifies a step-change in providing effective medicines for rare and non-rare diseases. However, to make this a reality, drug manufacturers have to contend with oligonucleotides’ poor pharmacokinetics and pharmacodynamics. Conjugation is a powerful strategy to help overcome these challenges. When designing effective therapeutic oligonucleotides, matching your conjugation strategy to your delivery objective is critical.With decades of expertise, Bachem is ideally placed to be a reliable partner for those seeking to bring the next generation of oligonucleotide therapeutics to market faster.For more information on using conjugation chemistry to improve oligonucleotide therapeutics, download our white paper or contact Bachem today and take advantage of our expertise.Unlock the Potential of Oligonucleotide TherapeuticDiscover how peptide conjugation is helping overcome delivery challenges and paving the way for next-generation oligonucleotide therapies. Get expert insights, strategies, and real-world examples in our latest whitepaper.Download nowSubscribe to our general newsletter/* "function"==typeof InitializeEditor,callIfLoaded:function(o){return!(!gform.domLoaded||!gform.scriptsLoaded||!gform.themeScriptsLoaded&&!gform.isFormEditor()||(gform.isFormEditor()&&console.warn("The use of gform.initializeOnLoaded() is deprecated in the form editor context and will be removed in Gravity Forms 3.1."),o(),0))},initializeOnLoaded:function(o){gform.callIfLoaded(o)||(document.addEventListener("gform_main_scripts_loaded",()=>{gform.scriptsLoaded=!0,gform.callIfLoaded(o)}),document.addEventListener("gform/theme/scripts_loaded",()=>{gform.themeScriptsLoaded=!0,gform.callIfLoaded(o)}),window.addEventListener("DOMContentLoaded",()=>{gform.domLoaded=!0,gform.callIfLoaded(o)}))},hooks:{action:{},filter:{}},addAction:function(o,r,e,t){gform.addHook("action",o,r,e,t)},addFilter:function(o,r,e,t){gform.addHook("filter",o,r,e,t)},doAction:function(o){gform.doHook("action",o,arguments)},applyFilters:function(o){return gform.doHook("filter",o,arguments)},removeAction:function(o,r){gform.removeHook("action",o,r)},removeFilter:function(o,r,e){gform.removeHook("filter",o,r,e)},addHook:function(o,r,e,t,n){null==gform.hooks[o][r]&&(gform.hooks[o][r]=[]);var d=gform.hooks[o][r];null==n&&(n=r+"_"+d.length),gform.hooks[o][r].push({tag:n,callable:e,priority:t=null==t?10:t})},doHook:function(r,o,e){var t;if(e=Array.prototype.slice.call(e,1),null!=gform.hooks[r][o]&&((o=gform.hooks[r][o]).sort(function(o,r){return o.priority-r.priority}),o.forEach(function(o){"function"!=typeof(t=o.callable)&&(t=window[t]),"action"==r?t.apply(null,e):e[0]=t.apply(null,e)})),"filter"==r)return e[0]},removeHook:function(o,r,t,n){var e;null!=gform.hooks[o][r]&&(e=(e=gform.hooks[o][r]).filter(function(o,r,e){return!!(null!=n&&n!=o.tag||null!=t&&t!=o.priority)}),gform.hooks[o][r]=e)}});/* ]]> */ "*" indicates required fields Δ/* Name* First Last Email Address*Country AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColombiaComorosCongoCongo, Democratic Republic of theCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d'IvoireDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHoly SeeHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKorea, Democratic People's Republic ofKorea, Republic ofKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacaoMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth MacedoniaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestine, State ofPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussian FederationRwandaRéunionSaint BarthélemySaint Helena, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwedenSwitzerlandSyria Arab RepublicTaiwanTajikistanTanzania, the United Republic ofThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkmenistanTurks and Caicos IslandsTuvaluTürkiyeUS Minor Outlying IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVenezuelaViet NamVirgin Islands, BritishVirgin Islands, U.S.Wallis and FutunaWestern SaharaYemenZambiaZimbabweÅland Islands Country Consent*Privacy Policy I have read, understood and agree to the Privacy Policy.This field is hidden when viewing the formSubmission Time Hours : Minutes /* = 0;if(!is_postback){return;}var form_content = jQuery(this).contents().find('#gform_wrapper_1');var is_confirmation = jQuery(this).contents().find('#gform_confirmation_wrapper_1').length > 0;var is_redirect = contents.indexOf('gformRedirect(){') >= 0;var is_form = form_content.length > 0 && ! is_redirect && ! is_confirmation;var mt = parseInt(jQuery('html').css('margin-top'), 10) + parseInt(jQuery('body').css('margin-top'), 10) + 100;if(is_form){jQuery('#gform_wrapper_1').html(form_content.html());if(form_content.hasClass('gform_validation_error')){jQuery('#gform_wrapper_1').addClass('gform_validation_error');} else {jQuery('#gform_wrapper_1').removeClass('gform_validation_error');}setTimeout( function() { /* delay the scroll by 50 milliseconds to fix a bug in chrome */ }, 50 );if(window['gformInitDatepicker']) {gformInitDatepicker();}if(window['gformInitPriceFields']) {gformInitPriceFields();}var current_page = jQuery('#gform_source_page_number_1').val();gformInitSpinner( 1, 'https://www.bachem.com/wp-content/plugins/gravityforms/images/spinner.svg', true );jQuery(document).trigger('gform_page_loaded', [1, current_page]);window['gf_submitting_1'] = false;}else if(!is_redirect){var confirmation_content = jQuery(this).contents().find('.GF_AJAX_POSTBACK').html();if(!confirmation_content){confirmation_content = contents;}jQuery('#gform_wrapper_1').replaceWith(confirmation_content);jQuery(document).trigger('gform_confirmation_loaded', [1]);window['gf_submitting_1'] = false;wp.a11y.speak(jQuery('#gform_confirmation_message_1').text());}else{jQuery('#gform_1').append(contents);if(window['gformRedirect']) {gformRedirect();}}jQuery(document).trigger("gform_pre_post_render", [{ formId: "1", currentPage: "current_page", abort: function() { this.preventDefault(); } }]); if (event && event.defaultPrevented) { return; } const gformWrapperDiv = document.getElementById( "gform_wrapper_1" ); if ( gformWrapperDiv ) { const visibilitySpan = document.createElement( "span" ); visibilitySpan.id = "gform_visibility_test_1"; gformWrapperDiv.insertAdjacentElement( "afterend", visibilitySpan ); } const visibilityTestDiv = document.getElementById( "gform_visibility_test_1" ); let postRenderFired = false; function triggerPostRender() { if ( postRenderFired ) { return; } postRenderFired = true; gform.core.triggerPostRenderEvents( 1, current_page ); if ( visibilityTestDiv ) { visibilityTestDiv.parentNode.removeChild( visibilityTestDiv ); } } function debounce( func, wait, immediate ) { var timeout; return function() { var context = this, args = arguments; var later = function() { timeout = null; if ( !immediate ) func.apply( context, args ); }; var callNow = immediate && !timeout; clearTimeout( timeout ); timeout = setTimeout( later, wait ); if ( callNow ) func.apply( context, args ); }; } const debouncedTriggerPostRender = debounce( function() { triggerPostRender(); }, 200 ); if ( visibilityTestDiv && visibilityTestDiv.offsetParent === null ) { const observer = new MutationObserver( ( mutations ) => { mutations.forEach( ( mutation ) => { if ( mutation.type === 'attributes' && visibilityTestDiv.offsetParent !== null ) { debouncedTriggerPostRender(); observer.disconnect(); } }); }); observer.observe( document.body, { attributes: true, childList: false, subtree: true, attributeFilter: [ 'style', 'class' ], }); } else { triggerPostRender(); } } );} ); /* ]]> */The post 5 Conjugate Reactions Improving Oligonucleotide Delivery appeared first on Bachem.Weiter zum vollständigen Artikel bei Bachem Holding AG Weiter zum vollständigen Artikel bei Bachem Holding AG